SYHA1402
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYHA1402, covering 2021-11-12 to 2021-11-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China [Phase 2]